Cartesian Therapeutics, Inc.: operating_income
| Value | {"amount": -56821000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | Cartesian Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/8a1708d2-b121-4b3f-8a20-7e09a905da24
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001453687-21-000031Retrieved: 2026-08-19T14:22:04.120658+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001453687/operating-income/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/8a1708d2-b121-4b3f-8a20-7e09a905da24
History
- no predecessors — first report